Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 4.4× sales vs its 15.7× historical median P/S.
Fair value ≈ $0.00 · price $0.00 today
Undervalued · 72% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$BIEL This Chairman’s Update is the strongest strategic communication BIEL has released in years.
It signals real operational progress, validated commercial traction, and a credible pathway toward sustained profitability — all supported by verifiable actions rather than vague forward-looking language.
The update contains four major signals:
BIEL is now profitable (even if small) due to disciplined cost control.
Sales are increasing monthly across both OTC and professional channels.
Electrome partnership has crossed the “execution threshold” — purchase order received, manufacturing underway, commercial launch planning active.
"Manufacturing activities are underway and Electrome is in the planning phase for a commercial launch of BioElectronics' ..."
Strategic positioning is shifting from survival to expansion, with clinical, consumer, professional, and international initiatives all advancing simultaneously.
This is not a “fluff” letter — it’s a milestone update....
(See posted on Ihub by 3331)
$BIEL Yeah it’s one of these gambling stocks that suck your money and have all sorts of of hopefuls but no turn outs.. Don’t waste your time or money here folks . I only bought 300 dollars worth and now it’s worth zilch so dont go crazy on it.. The craps table is keeping this junk alive
@Taz300 I’m also watching $BIEL. It’s mainly sentiment and low liquidity driven, so volatility is high. The key question is whether there’s sustained volume and real catalysts coming in. More suitable for tracking than aggressive chasing. Are you playing a bounce or long term? Follow me if interested, I can share my full view via DM.
$BIEL On a gamble bought 300 dollars worth of BIEL and noticed 24 billion outstanding shares… looks like a long wait and shares will be RSsd before anything happens
$BIEL RecoveryRx is made by Biel a leader in wearable drug free pulsed electromagnetic therapy (pemf) sells on ebay do ur dd company also makes ActiPatch!!
$BIEL Innovation Pipeline and Growth Catalysts
Haleon's developments include Voltaren ActiPatch hybrids integrating gels with wearable tech for chronic pain management, with Swiss pilots eyed for 2027 amid telemedicine growth. Partnerships with sports organizations boost visibility among younger users, driving trial rates. Monetization experiments like pharmacy subscriptions test recurring revenue models.
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-gel-haleon-s-powerhouse-in-swiss-pain-relief-market-stability/68683429
